KRAS and cancer: This finding is important especially with respect to glutamine metabolism, where KRAS-mutant cancer cells adapt to glutamine withdrawal by increasing asparagine biosynthesis via asparagine synthetase (ASNS), which allows cancer cells to survive [10].